Transluminal attenuation gradient derived from coronary CT angiography predicts anastomosis occlusion in coronary artery bypass grafts: a retrospective cohort study

冠状动脉CT血管造影衍生的管腔衰减梯度可预测冠状动脉旁路移植术吻合口闭塞:一项回顾性队列研究

阅读:3

Abstract

BACKGROUND: Predicting anastomotic occlusion remains a major challenge in the management of patients after coronary artery bypass grafting (CABG). This study aimed to evaluate the prognostic value of the transluminal attenuation gradient (TAG), a parameter derived from coronary computed tomography angiography (CCTA), for this complication. METHODS: In this retrospective cohort study, data from 160 patients with 327 anastomoses were analyzed. Postoperative CCTA was performed to assess graft characteristics and TAG. The primary endpoint was anastomosis occlusion, as confirmed by follow-up CCTA. Predictors of occlusion were identified through univariate and multivariate analyses. RESULTS: During follow-up, 57 (17.4%) anastomoses occluded. Compared with patent anastomoses, occluded grafts exhibited significantly more negative TAG values, shorter lengths, and smaller anastomotic diameters—including both proximal and distal dimensions. Multivariable analysis identified higher TAG (OR 0.892), longer graft length (OR 0.989), and larger distal anastomotic diameter (OR 0.157) as independent protective factors, whereas elevated total cholesterol (OR 9.404) and HbA1c (OR 1.672) emerged as independent risk factors. The predictive performance improved sequentially across models: a clinical model (AUC = 0.746), a model enhanced with anatomical variables (AUC = 0.864), and the final model incorporating TAG, which achieved the highest discriminatory power (AUC = 0.886). Nomograms were constructed to facilitate individualized risk prediction. CONCLUSION: TAG is a potent, independent predictor of anastomosis patency after CABG. Its integration into models combining clinical and anatomical variables significantly enhances risk stratification, offering a potential strategy for the early identification of high-risk patients who may benefit from targeted interventions to prolong graft patency. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12880-025-02063-8.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。